GSA Capital Partners’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.31M | Sell |
|
|||||
|
2025
Q3 | $1.59M | Sell |
|
|||||
|
2025
Q2 | $1.8M | Buy |
|
|||||
|
2025
Q1 | $1.19M | Buy |
|
|||||
|
2024
Q4 | $663K | Buy |
|
|||||
|
2024
Q3 | $143K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.01M | Sell |
|
|||||
|
2023
Q4 | $2.4M | Buy |
|
|||||
|
2023
Q3 | $1.75M | Buy |
|
|||||
|
2023
Q2 | $1.06M | Buy |
|
|||||
|
2023
Q1 | $593K | Sell |
|
|||||
|
2022
Q4 | $926K | Buy |
|
|||||
|
2022
Q3 | $512K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $322K | Buy |
|
|||||
|
2021
Q4 | $284K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $363K | Sell |
|
|||||
|
2019
Q3 | $698K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $312K | Sell |
|
|||||
|
2018
Q3 | $372K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $232K | Sell |
|
|||||
|
2016
Q3 | $296K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $261K | Buy |
|
|||||
|
2015
Q4 | $222K | Sell |
|
|||||
|
2015
Q3 | $594K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $240K | Sell |
|
|||||
|
2014
Q1 | $447K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $112K | Buy |
|